A cardiac stimulation assembly includes an energy source coupled to an
energy emitter that extends form a delivery member into a region of
tissue in the heart. An array of the emitters are adapted to extend from
a delivery assembly and into unique locations along the region of tissue,
such as by use of extendable, pre-shaped needles. A volume of conductive
agent is delivered into the region and enhances stimulation of the region
with the energy emitter. The agent may be an injectable preparation of
living cells that express production of connexin, e.g. connexin 43, and
may be genetically modified to over-express such production. The agent
may include a non-living material, such as conductive polymer or metal or
combination thereof. The combination of energy emitters and conductive
agent enhances stimulation of the region. Delivering the stimulation
assembly and conductive agent into the interventricular septum allows for
improved biventricular septal pacing.